ZG16 and adenocarcinoma: Furthermore, when compared to adenocarcinoma, patients with mucinous adenocarcinoma of colon (a more aggressive subtype) had lower copy number of ZG16. Thus, ZG16 might serve as a sensitive molecular marker for early detection and outcome prediction of colon cancer [15].